Proteomic Discovery and Validation of Novel Fluid Biomarkers for Improved Patient Selection and Prediction of Clinical Outcomes in Alzheimer’s Disease Patient Cohorts

Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by progressive cognitive decline. The two cardinal neuropathological hallmarks of AD include the buildup of cerebral β amyloid (Aβ) plaques and neurofibrillary tangles of hyperphosphorylated tau. The current disease-...

Descripción completa

Detalles Bibliográficos
Autores principales: Awasthi, Shivangi, Spellman, Daniel S., Hatcher, Nathan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397030/
https://www.ncbi.nlm.nih.gov/pubmed/35997438
http://dx.doi.org/10.3390/proteomes10030026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397030/
https://www.ncbi.nlm.nih.gov/pubmed/35997438
http://dx.doi.org/10.3390/proteomes10030026

Ejemplares similares